RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Apoptosis and mitochondrial DNA damaged induced by Zn(2 +) /Ca(2+) dual-ions overload for colorectal cancer improved immunotherapy.
Apoptosis and mitochondrial DNA damaged induced by Zn(2 +) /Ca(2+) dual-ions overload for colorectal cancer improved immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
基于免疫检查点抑制剂的肿瘤免疫治疗已显示出显著的临床获益;然而,由于T细胞对肿瘤微环境的浸润不足,其在结直肠癌(CRC)中的疗效仍然有限。
值得注意的是,靶向线粒体功能障碍或应激通路的治疗可以激活先天免疫并促进TIL(肿瘤浸润淋巴细胞)的募集。在本研究中,我们开发了经CaCO 3矿化的ZIF-8纳米颗粒(NPs),构建了ZIF-8@CaCO 3 NPs,旨在通过Zn/Ca离子双重过载增强肿瘤细胞损伤。ZIF-8@CaCO 3 NPs表现出最佳的粒径分布、优异的生物相容性,以及在弱酸性条件下释放Zn 2+和Ca 2+离子并随后产生活性氧的能力。
重要的是,Zn 2+和Ca 2+离子过载联合氧化应激破坏了线粒体稳态,导致氧化线粒体DNA的释放。这一过程刺激了先天免疫反应,包括直接抗肿瘤效应和CD8 + T细胞的募集。
此外,释放的mtDNA增强了树突状细胞的交叉呈递,进一步放大了抗肿瘤免疫反应。我们的研究结果表明,ZIF-8@CaCO 3 NPs在改善CRC免疫治疗结局方面具有巨大前景。
Immune checkpoint inhibitor-based cancer immunotherapy has demonstrated significant clinical benefits; however, its efficacy in colorectal cancer (CRC) remains limited owing to insufficient T-cell infiltration into the tumor microenvironment.
Notably, therapies targeting mitochondrial dysfunction or stress pathways can activate innate immunity and promote the recruitment of tumor-infiltrating lymphocytes. In this study, we developed ZIF-8 nanoparticles (NPs) mineralized with CaCO 3 to construct ZIF-8@CaCO 3 NPs, designed to enhance tumor cell damage via dual Zn/Ca ion overload. The ZIF-8@CaCO 3 NPs exhibited optimal size distribution, excellent biocompatibility, and the ability to release Zn 2+ and Ca 2+ ions under mildly acidic conditions, subsequently generating reactive oxygen species.
Importantly, an overload of Zn 2+ and Ca 2+ ions combined with oxidative stress disrupted mitochondrial homeostasis, leading to the release of oxidized mitochondrial DNA. This process stimulated innate immune responses, including a direct anti-tumor effect and the recruitment of CD8 + T cells.
Additionally, the released mtDNA enhanced cross-presentation in dendritic cells, further amplifying the anti-tumor immune response.
Our findings indicate that ZIF-8@CaCO 3 NPs hold great promise for improving immunotherapeutic outcomes in CRC.
MEMBER ACCOUNT
登录成功会直接打开下一页。